Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

East and North Hertfordshire NHS Trust60 enrolled

Overview

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Heart Failure

Interventions

HF-guided VAOTHER

VA guided recommendation

Standard-of-careOTHER

Standard-of-care

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years * Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge Exclusion Criteria * Known prior history of HF * Severe comorbidities that could affect protocol adherence, in the opinion of the investigator * Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease * Dementia or other cognitive impairment * Currently involved in another interventional clinical trial

Locations (1)

East and North Hertfordshire NHS Trust

Stevenage, Hertfordshire, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

Acceptability of the intervention to users (participants)

This will be assessed utilising an adapted 'acceptability of intervention measure' (AIM)

Time frame: 12 weeks

Central Contacts

Joshua H Leader, MBChB, BSc

CONTACT

07376188768 joshua.leader@nhs.net

Diana A Gorog, MD, PhD

CONTACT

01707247512 d.gorog@imperial.ac.uk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.